Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2,052 DKK | +1.33% | +2.25% | -4.97% |
04:14pm | Genmab CEO Says Western Firms Should Tap Into China's 'Impressive Innovation' | MT |
02:28pm | Bolt Biotherapeutics Stops Development of Trastuzumab Imbotolimod, Cuts Workforce by 50% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.97% | 1.9TCr | |
+5.73% | 11TCr | |
+11.65% | 11TCr | |
-12.61% | 2.22TCr | |
+0.35% | 2.13TCr | |
-35.21% | 1.85TCr | |
-11.19% | 1.68TCr | |
+37.84% | 1.25TCr | |
-25.04% | 808.97Cr | |
+297.61% | 799.44Cr |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Genmab, AbbVIe's Blood Cancer Therapy Lessens Symptoms in Early-stage Study